Paper36969340
Efficacy of faecal microbiota transplantation in patients with progressive supranuclear palsy-Richardson's syndrome: a phase 2, single centre, randomised clinical trial.
Tian H and 16 others. EClinicalMedicine, 2023. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Efficacy of faecal microbiota transplantation in patients with progressive supranuclear palsy-Richardson's syndrome: a phase 2, single centre, randomised clinical trial. Papers, record 36969340. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36969340
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy of faecal microbiota transplantation in patients with progressive supranuclear palsy-Richardson's syndrome: a phase 2, single centre, randomised clinical trial.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28087657 | European consensus conference on faecal microbiota transplantation in clinical practice. | Gut | 2017 | https://conductscience.org/library/papers/28087657 | PubMed |
| 2 | 35295092 | Bi-Directionality of the Microbiota-Gut-Brain Axis in Patients With Functional Dyspepsia: Relevance of Psychotherapy and Probiotics. | Front Neurosci | 2022 | https://conductscience.org/library/papers/35295092 | PubMed |
| 3 | 32409589 | Interaction between drugs and the gut microbiome. | Gut | 2020 | https://conductscience.org/library/papers/32409589 | PubMed |
| 4 | 34020973 | Intestinal barrier function in obesity with or without metabolic syndrome: a systematic review protocol. | BMJ Open | 2021 | https://conductscience.org/library/papers/34020973 | PubMed |
| 5 | 30576008 | Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism. | Mov Disord | 2019 | https://conductscience.org/library/papers/30576008 | PubMed |
| 6 | 20853098 | Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat. | Diabetologia | 2010 | https://conductscience.org/library/papers/20853098 | PubMed |
| 7 | 34996879 | Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease. | Neurology | 2022 | https://conductscience.org/library/papers/34996879 | PubMed |
| 8 | 26900156 | The Differential Diagnosis and Treatment of Atypical Parkinsonism. | Dtsch Arztebl Int | 2016 | https://conductscience.org/library/papers/26900156 | PubMed |
| 9 | 30579993 | Tau immunoreactivity in peripheral tissues of human aging and select tauopathies. | Neurosci Lett | 2019 | https://conductscience.org/library/papers/30579993 | PubMed |
| 10 | 25857665 | Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. | Gastroenterology | 2015 | https://conductscience.org/library/papers/25857665 | PubMed |
| 11 | 26628567 | Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection. | Clin Infect Dis | 2016 | https://conductscience.org/library/papers/26628567 | PubMed |
| 12 | 26948290 | Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy. | Mov Disord | 2016 | https://conductscience.org/library/papers/26948290 | PubMed |
| 13 | 34385707 | Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial. | Nat Med | 2021 | https://conductscience.org/library/papers/34385707 | PubMed |
| 14 | 28467028 | Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. | Mov Disord | 2017 | https://conductscience.org/library/papers/28467028 | PubMed |
| 15 | 8710059 | Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. | Neurology | 1996 | https://conductscience.org/library/papers/8710059 | PubMed |
| 16 | 34579087 | Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review. | Nutrients | 2021 | https://conductscience.org/library/papers/34579087 | PubMed |
| 17 | 35650236 | Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson's disease. | NPJ Parkinsons Dis | 2022 | https://conductscience.org/library/papers/35650236 | PubMed |
| 18 | 17405767 | A clinical rating scale for progressive supranuclear palsy. | Brain | 2007 | https://conductscience.org/library/papers/17405767 | PubMed |
| 19 | 29555994 | Extensive impact of non-antibiotic drugs on human gut bacteria. | Nature | 2018 | https://conductscience.org/library/papers/29555994 | PubMed |
| 20 | 29471030 | Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway. | Brain Behav Immun | 2018 | https://conductscience.org/library/papers/29471030 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42849176 | Immune effects of faecal microbiota transplantation in amyotrophic lateral sclerosis: a pilot multicentre, randomised, masked, sham-controlled, proof-of concept trial. | EBioMedicine | 2026 | https://conductscience.org/library/papers/42849176 | PubMed |
| 42754368 | Gut microbiome dysbiosis, short-chain fatty acid depletion and implications for neuroinflammation in atypical parkinsonian syndromes - a systematic review of patient cohorts. | J Parkinsons Dis | 2026 | https://conductscience.org/library/papers/42754368 | PubMed |
| 42473187 | Akkermansia muciniphila enhances washed microbiota transplantation in the treatment of epilepsy. | Chin Med J (Engl) | 2026 | https://conductscience.org/library/papers/42473187 | PubMed |
| 42211787 | Metagenomic profiling of ocular surface microbiome alterations in patients with progressive supranuclear palsy-Richardson's syndrome. | Curr Res Microb Sci | 2026 | https://conductscience.org/library/papers/42211787 | PubMed |
| 42158808 | Changes in bowel-movement frequency, gut microbiota, and emotional issues in postoperative constipation patients. | Gastroenterol Rep (Oxf) | 2026 | https://conductscience.org/library/papers/42158808 | PubMed |
| 42021371 | Microbiota as a regulator of brain vulnerability across lifespan and disease contexts. | J Neuroinflammation | 2026 | https://conductscience.org/library/papers/42021371 | PubMed |
| 41826284 | Gut microbiota modulation via repeated donor fecal transplantation improves motor and gastrointestinal symptoms in drug-naïve Parkinson's disease: a randomized phase 2 trial. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41826284 | PubMed |
| 41395455 | Progress of non-motor symptoms in early-onset Parkinson's disease. | Ibrain | 2025 | https://conductscience.org/library/papers/41395455 | PubMed |
| 41122746 | Clinical efficacy of fecal microbiota transplantation in alleviating depressive symptoms: a meta-analysis of randomized trials. | Front Psychiatry | 2025 | https://conductscience.org/library/papers/41122746 | PubMed |
| 41097234 | Polygonatum sibiricum Polysaccharides Alleviate Simulated Weightlessness-Induced Cognitive Impairment by Gut Microbiota Modulation and Suppression of NLRP3/NF-κB Pathways. | Nutrients | 2025 | https://conductscience.org/library/papers/41097234 | PubMed |
| 40362171 | Role of the Intestinal Microbiota in the Molecular Pathogenesis of Atypical Parkinsonian Syndromes. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362171 | PubMed |
| 40060755 | Fecal microbiota transplantation for the treatment of intestinal and extra-intestinal diseases: Mechanism basis, clinical application, and potential prospect. | Bioeng Transl Med | 2025 | https://conductscience.org/library/papers/40060755 | PubMed |
| 40002492 | The Inflammatory Mechanism of Parkinson's Disease: Gut Microbiota Metabolites Affect the Development of the Disease Through the Gut-Brain Axis. | Brain Sci | 2025 | https://conductscience.org/library/papers/40002492 | PubMed |
| 39713959 | The Effect of Alcohol Consumption on Progressive Supranuclear Palsy: A Cross-Sectional Study. | CNS Neurosci Ther | 2024 | https://conductscience.org/library/papers/39713959 | PubMed |
| 39617896 | Effect of fecal microbiota transplantation on patients with sporadic amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial. | BMC Med | 2024 | https://conductscience.org/library/papers/39617896 | PubMed |
| 39582897 | Colonic transendoscopic enteral tubing is revolutionizing intestinal therapeutics, diagnosis, and microbiome research. | Ther Adv Gastroenterol | 2024 | https://conductscience.org/library/papers/39582897 | PubMed |
| 39421569 | The possible connection between neutrophil-to-high-density lipoprotein ratio and cerebral perfusion in clinically established corticobasal syndrome: a pilot study. | Front Neurol | 2024 | https://conductscience.org/library/papers/39421569 | PubMed |
| 38964948 | An emerging role for the gut microbiome in tauopathy. | Neurotherapeutics | 2024 | https://conductscience.org/library/papers/38964948 | PubMed |
| 38237031 | The contribution of age-related changes in the gut-brain axis to neurological disorders. | Gut Microbes | 2024 | https://conductscience.org/library/papers/38237031 | PubMed |
| 37893413 | Analysis of Genetic and MRI Changes, Blood Markers, and Risk Factors in a Twin Pair Discordant of Progressive Supranuclear Palsy. | Medicina (Kaunas) | 2023 | https://conductscience.org/library/papers/37893413 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDH1 | 999 | PubTator's text mining | https://conductscience.org/library/genes/999 | NCBI Gene |
| CLDN5 | 7122 | PubTator's text mining | https://conductscience.org/library/genes/7122 | NCBI Gene |
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| HP | 3240 | PubTator's text mining | https://conductscience.org/library/genes/3240 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| OCLN | 100506658 | PubTator's text mining | https://conductscience.org/library/genes/100506658 | NCBI Gene |
| SERPINA1 | 5265 | PubTator's text mining | https://conductscience.org/library/genes/5265 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36969340
GET https://conductscience.org/api/papers/v1/36969340/references?page=2